News & Updates
Filter by Specialty:

High glycaemic burden associated with HCC development and fibrosis progression in patients with CHB + T2D
High glycaemic burden is associated with hepatocellular carcinoma (HCC) development and fibrosis progression in patients with chronic hepatitis B (CHB) and type 2 diabetes (T2D) (CHB + T2D), researchers from the University of Hong Kong (HKU) have reported.
High glycaemic burden associated with HCC development and fibrosis progression in patients with CHB + T2D
08 Nov 2022
Finerenone shields against pneumonia, COVID-19 in diabetic patients with CKD
Patients with concomitant chronic kidney disease (CKD) and type 2 diabetes (T2D) who are undergoing mineralocorticoid receptor blockade with finerenone are better protected against pneumonia and COVID-19, according to a secondary analysis of data from the FIDELITY trials.
Finerenone shields against pneumonia, COVID-19 in diabetic patients with CKD
02 Nov 2022
Gestational diabetes diagnosis: Does lower glycaemic threshold affect maternal, birth outcomes?
Using a lower glycaemic threshold led to more diagnoses of gestational diabetes, though its impact on maternal and birth outcomes remains uncertain, results of the GEMS* trial showed.
Gestational diabetes diagnosis: Does lower glycaemic threshold affect maternal, birth outcomes?
01 Nov 2022
4 anti-obesity meds: AGA top picks
Obese adults with weight-related complications who do not respond adequately to lifestyle interventions should be offered one of four anti-obesity medications, according to the new clinical practice guideline on pharmacological interventions released by the American Gastroenterological Association (AGA).